Skip to content

Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrier

Feasibility study of risk reducing salpingo-oophorectomy for BRCA1/2 mutation carrier - RRSO for BRCA1/2 mutation carrier

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033384
Enrollment
8
Registered
2018-07-17
Start date
2019-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast ovarian cancer syndrome

Interventions

risk reducing sapling-oophorectomy

Sponsors

Yamaguchi University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.BRCA mutant carrier 2.no prior ovarian cancer 3.wish for operation after counseling 4.no wish for pregnancy 5.over 35 years old

Exclusion criteria

Exclusion criteria: no mutation of BRCA

Design outcomes

Primary

MeasureTime frame
Rate of adverse event intra- or after operation

Secondary

MeasureTime frame
Rate of operation associated death Incidence of of occult cancer

Countries

Japan

Contacts

Public ContactKotaro Sueoka

Yamaguchi University Obstetrics and Gynecology

obgyn@yamaguchi-u.ac.jp0836-22-2288

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026